Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

PharmaZen doubles capacity to keep up with demand

PharmaZen doubles capacity to keep up with demand


Freeze dryer ­
PharmaZen chief executive Craig McIntosh inspects product
coming from the new freeze dryer.
Click to enlarge

Freeze dryer ­ PharmaZen chief executive Craig McIntosh inspects product coming from the new freeze dryer.

Freeze dryer ­
PharmaZen chief executive Craig McIntosh inspects product
coming from the new freeze dryer.
Click to enlarge

Freeze dryer ­ PharmaZen chief executive Craig McIntosh inspects product coming from the new freeze dryer.

For Immediate Release

Thursday, November 2

PharmaZen doubles capacity to keep up with demand


Biotechnology company PharmaZen has just invested $1m in plant and machinery which will double the company's potential turnover from $7 million to $14 million per year.

With demand outstripping supply for the company's animal and human health products, the cost of the new plant will be recovered very quickly.

Shares in PharmaZen are traded through the unregistered securities trading facility.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

PharmaZen chief executive, Craig McIntosh, said the investment has predominantly been in milling and drying while other efficiencies had also been gained on the operational side with a significant investment in a heat recovery system.

The Company's most notable investment has been in a purpose designed vacuum drying system which can also be operated as a wet processing unit.

"We had looked around for an off the shelf solution which would enable us to wet process product and then continue through into a drying stage without the need to transfer product to another vessel (traditional technology). When we couldn't find a suitable solution we looked at the feasibility of having one designed and built, which is what we did."

The unit was finally commissioned in October and the company is extremely happy with the results, reporting not only the anticipated increase in throughput but an improvement in product yield due to reduced handling losses.

"There were a lot of teething problems which were always to be expected on such an innovative project and overall it took a lot longer than anticipated to have it up and running but in terms of performance it is better than we could have hoped for."

The plant upgrade is scheduled for completion early next month.

The new plant has been installed in PharmaZen's wholly-owned Waitaki Biosciences International unit in Christchurch where it manufactures a range of powder products extracted from a wide range of animal and marine sources. The range includes green-lipped mussel, shark cartilage, natural calcium and Chondroitin Sulphate. The products are used by other companies as a base for health products, mainly in the areas of bone health, joint health, immune and digestive support.


"We have always struggled to keep up with demand. Our level of efficiency was poor but that has increased markedly over the last 12 months and now we have the capacity to go to a new level," he said.

The company reported a loss of $183,000 on turnover of $5.58million for the 2005 year. It anticipates turnover of $6 million for 2006 with a significant lift in profit.


ENDS

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.